DAP:ETR
Danaher Corp
209,90 €
arrow_downward
−0,33%(−0,70) 1D
17. stu, 17:30:00 GMT+1 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za DAP...
Otvori
208,60 €
Najviša
209,90 €
Najniža
207,70 €
Trž. kap.
158,84 mlr.
Prosj. kol.
520,00
Količina
410,00
52-tjed. najviša
214,50 €
52-tjed. najniža
138,20 €
Broj djelatnika
59 tis.
Otvori
208,60 €
Najviša
209,90 €
Najniža
207,70 €
Trž. kap.
158,84 mlr.
Prosj. kol.
520,00
Količina
410,00
52-tjed. najviša
214,50 €
52-tjed. najniža
138,20 €
Broj djelatnika
59 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Investing.com
·
prije 12 sati
Danaher at Jefferies Global Healthcare Conference: growth plan takes shape
Profil
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
Danaher Corp – informacije
Glavni izvršni direktorRainer M. Blair
Zaposlenici59 tis.
Osnovano1969
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijadanaher.com